Sangamo Therapeutics Inc (NASDAQ: SGMO) kicked off on Monday, up 3.85% from the previous trading day, before settling in for the closing price of $1.30. Over the past 52 weeks, SGMO has traded in a range of $0.30-$3.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 16.98% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 68.32%. With a float of $199.18 million, this company’s outstanding shares have now reached $208.62 million.
In an organization with 405 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 84.55%, operating margin of -256.63%, and the pretax margin is -257.89%.
Sangamo Therapeutics Inc (SGMO) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Sangamo Therapeutics Inc is 4.54%, while institutional ownership is 27.06%.
Sangamo Therapeutics Inc (SGMO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 68.32% per share during the next fiscal year.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Trading Performance Indicators
Take a look at Sangamo Therapeutics Inc’s (SGMO) current performance indicators. Last quarter, stock had a quick ratio of 1.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.74, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.25 in one year’s time.
Technical Analysis of Sangamo Therapeutics Inc (SGMO)
Let’s dig in a bit further. During the last 5-days, its volume was 20.36 million. That was better than the volume of 12.69 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.04%. Additionally, its Average True Range was 0.33.
During the past 100 days, Sangamo Therapeutics Inc’s (SGMO) raw stochastic average was set at 26.22%, which indicates a significant increase from 22.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 386.09% in the past 14 days, which was higher than the 187.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.1017, while its 200-day Moving Average is $1.0296. However, in the short run, Sangamo Therapeutics Inc’s stock first resistance to watch stands at $1.4333. Second resistance stands at $1.5167. The third major resistance level sits at $1.5833. If the price goes on to break the first support level at $1.2833, it is likely to go to the next support level at $1.2167. The third support level lies at $1.1333 if the price breaches the second support level.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Key Stats
The company with the Market Capitalisation of 281.67 million has total of 208,647K Shares Outstanding. Its annual sales at the moment are 176,230 K in contrast with the sum of -257,830 K annual income. Company’s last quarter sales were recorded 49,410 K and last quarter income was 10,670 K.
